top
Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 01/10/2016 Item size : 333679 bytes
Eurointervention

EuroIntervention Impact of stent type and prolonged DAPT on long-term clinical outcomes in haemodialysis patients with coronary artery disease Asami M., Aoki J., Sato T., Tanimoto S., Watanabe M., ...

Date : 06/05/2016 Item size : 31385 bytes
Eurointervention

METHODS AND RESULTS From April 2015 to January 2016, a total of 22 coronary lesions in 16 patients at risk for major bleeding were treated by PCI with the bioengineered Combo Dual Therapy Stent prior ...

Date : 06/05/2016 Item size : 32097 bytes
Eurointervention

EuroIntervention Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet ...

Date : 12/02/2016 Item size : 35796 bytes
Eurointervention

EuroIntervention Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes ...

Date : 21/02/2011 Item size : 34820 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 21/04/2016
Ehjournal

Optimizing dual antiplatelet therapy duration after myocardial infarction: evidence-based, precision, or personalized medicine? The cardiovascular field is the medical discipline publishing the ...

European Heart Journal, Alfonso, Fernando, Jiménez-Borreguero, Luis Jesús

Date : 07/04/2017 Item size : 112311 bytes
Ehjournal

Optimizing dual antiplatelet therapy duration after myocardial infarction: evidence-based, precision, or personalized medicine? The cardiovascular field is the medical discipline publishing the ...

European Heart Journal, Alfonso, Fernando, Jiménez-Borreguero, Luis Jesús

Date : 07/04/2017
Escardio

Barcelona, Spain – Tuesday 26 August 2014: A new European joint consensus document on the use of antithrombotic drugs, including the non-vitamin K antagonist oral anticoagulants (NOACs), in ...

Date : 26/08/2014